Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk

Klinische Wochenschrift

Volumn 66, Issue SUPPL. 11, 1988, Pages 87-97

  Roots, I ^a   Drakoulis, N ^a   Ploch, M ^a   Heinemeyer, G ^a   Loddenkemper, R ^a   Minks, T ^a   Nitz, M ^a   Otte, F ^a   Koch, M ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DEBRISOQUINE;

ACETYLATION; BLOOD GROUP; BLOOD GROUP ABO SYSTEM; DISEASE PREDISPOSITION; ETIOLOGY; HUMAN; HYDROXYLATION; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

ABO BLOOD-GROUP SYSTEM; ACETYLATION; ACETYLTRANSFERASES; ARYLAMINE N-ACETYLTRANSFERASE; CAFFEINE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; DEBRISOQUIN; HUMAN; LUNG NEOPLASMS; MIXED FUNCTION OXYGENASES; PHENOTYPE; POLYMORPHISM (GENETICS); RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0023795221     PISSN: 00232173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)